DNA vaccination with VP2 gene fragment confers protection against Infectious Bursal Disease Virus in Chickens

Veterinary Microbiology

Volumn 171, Issue 1-2, 2014, Pages 13-22

  Pradhan, Satya Narayan ^a   Prince, Prabhu Rajaiah ^a   Madhumathi, Jayaprakasam ^a   Arunkumar, Chakkaravarthy ^a   Roy, Parimal ^b   Narayanan, Rangarajan Badri ^a   Antony, Usha ^a  

^a ANNA UNIVERSITY   (India)

^b MADRAS VETERINARY COLLEGE   (India)

Author keywords

Chicken; DNA vaccine; IBDV; Immune response; VP2

Indexed keywords

DNA VACCINE; PLASMID DNA; PROTEIN VP2; PVAXVP2 [52-147] VACCINE; RECOMBINANT ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBODY TITER; ARTICLE; CHICKEN; CHO CELL LINE; CONTROLLED STUDY; DNA IMMUNIZATION; DNA VECTOR; GENE EXPRESSION; GENE INSERTION; GENETIC TRANSFECTION; IMMUNITY; IMMUNOGENICITY; IN VITRO STUDY; INFECTIOUS BURSAL DISEASE VIRUS; MOLECULAR CLONING; NONHUMAN; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN CELL; TISSUE DISTRIBUTION; VIRUS INFECTION; WESTERN BLOTTING;

GALLUS GALLUS; INFECTIOUS BURSAL DISEASE VIRUS;

CHICKEN; DNA VACCINE; IBDV; IMMUNE RESPONSE; PVAXVP2(52-417); VP2;

ANIMALS; ANTIBODIES, VIRAL; BIRNAVIRIDAE INFECTIONS; BURSA OF FABRICIUS; CAPSID PROTEINS; CHICKENS; CHO CELLS; CRICETULUS; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; INFECTIOUS BURSAL DISEASE VIRUS; MUSCLE, SKELETAL; PLASMIDS; POULTRY DISEASES; SPECIFIC PATHOGEN-FREE ORGANISMS; SURVIVAL ANALYSIS; T-LYMPHOCYTES; VACCINATION; VACCINES, DNA; VIRAL VACCINES;

EID: 84899969190     PISSN: 03781135     EISSN: 18732542     Source Type: Journal    
DOI: 10.1016/j.vetmic.2014.02.019     Document Type: Article

References (35)

1. Azad A.A., Jagdish M.N., Brown M.A., Hudson P.J. Deletion mapping and expression in Escherichia coli of the large genomic segments of a birnavirus. Virology 1987, 161:145-152.
2. Azad A.A., McKern N.M., Macreadie I.G., Failla P., Heine H.G., Chapman A., Ward C.W., Fahey K.J. Physicochemical and immunological characterization of recombinant host-protective antigen (VP2) of infectious bursal disease virus. Vaccine 1991, 9:715-722.
3. Dohms J.E., Jaeger J.S. The effect of infectious bursal disease virus infection on local and systemic antibody responses following infection of 3-week old broiler chickens. Avian Disease 1998, 32:632-640.
4. Donnelly J.J., Ulmer J.B., Shiver J.W., Liu M.A. DNA vaccines. Annual Review of Immunology 1997, 15:617-648.
5. Donnelly J.J., Liu M.A., Ulmer J.B. Antigen presentation and DNA vaccines. American Journal of Respiratory and Critical Care Medicine 2000, 162:190-193.
6. Doria-Rose N.A., Haigwood N.L. DNA vaccine strategies: candidates for immune modulation and immunization regimens. Methods 2003, 31:207-216.
7. Fahey K.J., Erny K., Crooks J. A conformational immunogen on VP2 of infectious bursal disease virus that induces virus-neutralizing antibodies that passively protect chickens. Journal of General Virology 1989, 70:1473-1481.
8. Fuller D.H., Rajakumar P., Che J.W., Narendran A., Nyaundi J., Michael H., Yager E.J., Stagnar C., Wahlberg B., Taber R., Haynes J.R., Cook F.C., Ertl P., Tite J., Amedee A.M., Murphey-Corb M. Therapeutic DNA vaccine induces broad T cell responses in the gut and sustained protection from viral rebound and AIDS in SIV-infected rhesus macaques. PLoS ONE 2012, 7:e33715.
9. Fussell L.W. Poultry industry strategies for control of immunosuppressive diseases. Poultry Science 1998, 77:1193-1196.
10. Garver K.A., Conway C.M., Elliott D.G., Kurath G. Analysis of DNA-vaccinated fish reveals viral antigen in muscle, kidney and thymus, and transient histopathologic changes. Marine Biotechnology 2005, 7:540-553.
11. Heine H.G., Haritou M., Failla P., Fahey K., Azad A.A. Sequence analysis and expression of the host protective immunogen VP2 of variant strain of IBDV which can circumvent vaccination with standard type 1 strain. Journal of General Virology 1991, 72:1835-1843.
12. Hooper J.W., Custer D.M., Thompson E. Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates. Virology 2003, 306:181-195.
13. Hulse D.J., Romero C.H. Fate of plasmid DNA encoding infectious bursal disease virus VP2 capsid protein gene after injection into the pectoralis muscle of the chicken. Poultry Science 2002, 81:213-216.
14. Khanolkar A., Fuller M.J., Zajac A.J. T cell responses to viral infections: lessons from lymphocytic choriomeningitis virus. Immunologic Research 2002, 26:309-321.
15. Laemmli E.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
16. Lewis P.J., Babiuk L.A. DNA vaccines: a review. Advances in Virus Research 1999, 54:129-188.
17. Lombardo E., Maraver A., Espinosa I., Fernandez-Aris A., Rodriguez J.F. VP5, the nonstructural polypeptide of infectious bursal disease virus, accumulates within the host plasma membrane and induces cell lysis. Virology 2000, 277:345-357.
18. Lukert P.D., Saif Y.M. Infectious bursal disease. Disease of Poultry 2003, 161-179. Iowa State University, Ames, Iowa, USA. 11th ed. Y.M. Saif (Ed.).
19. Mena A., Andrew M.E., Coupar B.E. Rapid dissemination of intramuscularly inoculated DNA vaccines. Immunology and Cell Biology 2001, 79:87-89.
20. Müller H., Islam M.R., Raue R. Research on infectious bursal disease - the past, the present and the future. Veterinary Microbiology 2003, 97:153-165.
21. Mundt E., Beyer J., Muller H. Identification of a novel viral protein in infectious disease virus-infected cells. Journal of General Virology 1995, 76:437-443.
22. Oshop G.L., Elankumaran S., Heckert R.A. DNA vaccination in the avian. Veterinary Immunology and Immunopathology 2002, 89:1-12.
23. Parker S.E., Borellini F., Wenk M.L., Hobart P., Hoffman S.L., Hedstrom R., Le T., Norman J.A. Plasmid DNA malaria vaccine: tissue distribution and safety studies in mice and rabbits. Human Gene Therapy 1999, 10:741-758.
24. Pitcovski J., Gutter B., Gallilib G., Goldwaya M., Perelmanb B., Grossa G. Development and large-scale use of recombinant VP2 vaccine for the prevention of infectious bursal disease of chickens. Vaccine 2003, 21:4736-4743.
25. Rautenschlein S., Kraeme C., Vanmarcke J., Montiel E. Protective efficacy of intermediate and intermediate plus infectious bursal disease virus (IBDV) vaccines against very virulent IBDV in commercial broilers. Avian Disease 2005, 49:231-237.
26. Robinson H.L., Hunt L.A., Webste R.G. Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA. Vaccine 1993, 19:957-960.
27. Rong J., Cheng T.P., Liu X.N., Jiang T.Z., Gu H., Zou G.L. Development of recombinant VP2 vaccine for the prevention of infectious bursal disease of chickens. Vaccine 2005, 23:4844-4851.
28. Pradhan S.N., Prince P.R., Madhumathi J., Roy P., Narayanan R.B., Antony U. Protective immune responses of recombinant VP2 subunit antigen of infectious bursal disease virus in chickens. Veterinary Immunology and Immunopathology 2012, 148:293-301.
29. Snyder D.B. Changes in the field status of infectious bursal disease virus. Avian Pathology 1990, 19:419-423.
30. Spies U., Müller H., Becht H. Properties of RNA polymerase activity associated with infectious bursal disease virus and characterization of its reaction products. Virus Research 1987, 8:127-140.
31. Van Drunen L.H.S., Gerdts V., Loehr B.I., Pontarollo R., Rankin R., Uwiera R. Recent advances in the use of DNA vaccines for the treatment of diseases of farmed animals. Advanced Drug Delivery Reviews 2000, 43:13-28.
32. Wolff J.A., Malone R.W., Williams P., Chong W., Acsadi G., Jani A., Felgner P.L. Direct gene transfer into mouse muscle in vivo. Science 1990, 247:1465-1468.
33. Wong H.T., Cheng S.C., Chan E.W., Sheng Z.T., Yan W.Y., Zheng Z.X. Plasmids encoding foot-and-mouth disease virus SG epitopes elicited immune responses in mice and swine and protected swine against viral infection. Virology 2000, 278:27-35.
34. Yamaguchi T., Iwata K., Kobayashi M., Ogawa M., Fukushi H., Hirai K. Epitope mapping of capsid proteins VP2 and VP3 of IBDV. Archives of Virology 1996, 141:1493-1507.
35. Yen-Hung C., Bor-Luen C., Yueh-Lun L., Wei-Kuang C., Wen-Chang L., Yen-Teen C., Mi-Hua T. Development of Th1 and Th2 populations and the nature of immune responses to Hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes. Journal of Immunology 1998, 160:1320-1329.